Ligand validation:4KAH

BYZ: 4-bromo-1H-pyrazole

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4KAH_BYZ_A_404	61%	0%	0.144	0.934	2.77	7.48	2	4	2	0	100%	1
4KAH_BYZ_B_501	44%	0%	0.158	0.887	2.77	7.81	2	5	2	0	100%	1
9ETP_BYZ_A_601	100%	16%	0.024	0.998	0.74	2.74	-	3	0	0	100%	0.5
8CZM_BYZ_A_201	94%	78%	0.076	0.983	0.37	0.43	-	-	0	0	100%	1
5CXR_BYZ_A_305	69%	5%	0.143	0.963	1.57	3.66	1	3	0	0	100%	1
6Q3C_BYZ_A_302	57%	33%	0.129	0.905	0.44	2.07	-	2	4	0	100%	0.5
5CYQ_BYZ_A_608	46%	0%	0.172	0.909	2.56	6.67	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.